Industry
Biotechnology
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.
Loading...
Open
1.50
Mkt cap
249M
Volume
1.3M
High
1.57
P/E Ratio
24.33
52-wk high
21.09
Low
1.37
Div yield
N/A
52-wk low
0.26
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.